232 related articles for article (PubMed ID: 24573549)
1. A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells.
Hight MR; Cheung YY; Nickels ML; Dawson ES; Zhao P; Saleh S; Buck JR; Tang D; Washington MK; Coffey RJ; Manning HC
Clin Cancer Res; 2014 Apr; 20(8):2126-35. PubMed ID: 24573549
[TBL] [Abstract][Full Text] [Related]
2. Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis.
Qiu L; Wang W; Li K; Peng Y; Lv G; Liu Q; Gao F; Seimbille Y; Xie M; Lin J
Theranostics; 2019; 9(23):6962-6975. PubMed ID: 31660080
[No Abstract] [Full Text] [Related]
3. 3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer.
McKinley ET; Smith RA; Zhao P; Fu A; Saleh SA; Uddin MI; Washington MK; Coffey RJ; Manning HC
J Nucl Med; 2013 Mar; 54(3):424-30. PubMed ID: 23341544
[TBL] [Abstract][Full Text] [Related]
4. Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAF
Schulte ML; Hight MR; Ayers GD; Liu Q; Shyr Y; Washington MK; Manning HC
Mol Imaging Biol; 2017 Jun; 19(3):421-428. PubMed ID: 27770401
[TBL] [Abstract][Full Text] [Related]
5. Necrostatin-1 Synergizes the Pan Caspase Inhibitor to Attenuate Lung Injury Induced by Ischemia Reperfusion in Rats.
Wang L; Chen B; Xiong X; Chen S; Jin L; Zhu M
Mediators Inflamm; 2020; 2020():7059304. PubMed ID: 33162831
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.
Fuereder T; Wanek T; Pflegerl P; Jaeger-Lansky A; Hoeflmayer D; Strommer S; Kuntner C; Wrba F; Werzowa J; Hejna M; Müller M; Langer O; Wacheck V
Clin Cancer Res; 2011 Aug; 17(16):5322-32. PubMed ID: 21712451
[TBL] [Abstract][Full Text] [Related]
7. Imaging colon cancer response following treatment with AZD1152: a preclinical analysis of [18F]fluoro-2-deoxyglucose and 3'-deoxy-3'-[18F]fluorothymidine imaging.
Moroz MA; Kochetkov T; Cai S; Wu J; Shamis M; Nair J; de Stanchina E; Serganova I; Schwartz GK; Banerjee D; Bertino JR; Blasberg RG
Clin Cancer Res; 2011 Mar; 17(5):1099-110. PubMed ID: 21245090
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody.
Chen DL; Zhou D; Chu W; Herrbrich P; Engle JT; Griffin E; Jones LA; Rothfuss JM; Geraci M; Hotchkiss RS; Mach RH
Nucl Med Biol; 2012 Jan; 39(1):137-44. PubMed ID: 22033021
[TBL] [Abstract][Full Text] [Related]
9. Suppression of human T cell proliferation by the caspase inhibitors, z-VAD-FMK and z-IETD-FMK is independent of their caspase inhibition properties.
Lawrence CP; Chow SC
Toxicol Appl Pharmacol; 2012 Nov; 265(1):103-12. PubMed ID: 22982538
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumors.
Xia CF; Chen G; Gangadharmath U; Gomez LF; Liang Q; Mu F; Mocharla VP; Su H; Szardenings AK; Walsh JC; Zhao T; Kolb HC
Mol Imaging Biol; 2013 Dec; 15(6):748-57. PubMed ID: 23689985
[TBL] [Abstract][Full Text] [Related]
11. Temporal and spatial evolution of therapy-induced tumor apoptosis detected by caspase-3-selective molecular imaging.
Nguyen QD; Lavdas I; Gubbins J; Smith G; Fortt R; Carroll LS; Graham MA; Aboagye EO
Clin Cancer Res; 2013 Jul; 19(14):3914-24. PubMed ID: 23729364
[TBL] [Abstract][Full Text] [Related]
12. Imaging caspase-3 activation as a marker of apoptosis-targeted treatment response in cancer.
Chen DL; Engle JT; Griffin EA; Miller JP; Chu W; Zhou D; Mach RH
Mol Imaging Biol; 2015 Jun; 17(3):384-93. PubMed ID: 25344147
[TBL] [Abstract][Full Text] [Related]
13. Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis.
Johnson VL; Ko SC; Holmstrom TH; Eriksson JE; Chow SC
J Cell Sci; 2000 Sep; 113 ( Pt 17)():2941-53. PubMed ID: 10934034
[TBL] [Abstract][Full Text] [Related]
14. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
[TBL] [Abstract][Full Text] [Related]
15. Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(O-methyl)-fluoromethyl ketone.
Haberkorn U; Kinscherf R; Krammer PH; Mier W; Eisenhut M
Nucl Med Biol; 2001 Oct; 28(7):793-8. PubMed ID: 11578900
[TBL] [Abstract][Full Text] [Related]
16. Comparison of (18)F-labeled CXCR4 antagonist peptides for PET imaging of CXCR4 expression.
Zhang XX; Sun Z; Guo J; Wang Z; Wu C; Niu G; Ma Y; Kiesewetter DO; Chen X
Mol Imaging Biol; 2013 Dec; 15(6):758-67. PubMed ID: 23636490
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [
Sun P; Han Y; Zhu Y; Hu K; Huang S; Tan J; Wang M; Wu H; Tang G
Nucl Med Biol; 2020; 88-89():1-9. PubMed ID: 32580089
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of [
Rapic S; Vangestel C; Elvas F; Verhaeghe J; den Wyngaert TV; Wyffels L; Pauwels P; Staelens S; Stroobants S
Mol Imaging Biol; 2017 Aug; 19(4):560-569. PubMed ID: 28050749
[TBL] [Abstract][Full Text] [Related]
19. Detection of caspase activation in situ by fluorochrome-labeled caspase inhibitors.
Amstad PA; Yu G; Johnson GL; Lee BW; Dhawan S; Phelps DJ
Biotechniques; 2001 Sep; 31(3):608-10, 612, 614, passim. PubMed ID: 11570504
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Evaluation of [
Huang J; Bai L; Shi D; Jiang W; Chen P; Dong Y; Zhang X; Peng J; Hou J; Lu Y; Huang X; Tang G; Huang S
Mol Pharm; 2024 May; 21(5):2425-2434. PubMed ID: 38554143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
